Drug Shortage Report for HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ
| Report ID | 133662 |
| Drug Identification Number | 02209721 |
| Brand name | HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ |
| Common or Proper name | Heparin Sodium in 5% Dextrose |
| Company Name | B. BRAUN MEDICAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPARIN SODIUM DEXTROSE |
| Strength(s) | 10000UNIT 5G |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 250mL |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2021-02-01 |
| Estimated end date | 2021-02-26 |
| Actual end date | 2021-02-26 |
| Shortage status | Resolved |
| Updated date | 2021-02-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 824 TWELFTH AVENUE BETHLEHEM, PENNSYLVANIA UNITED STATES 18018 |
| Company contact information | Cindy Katsempris; cindy.katsempris@bbraunusa.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-02-27 | English | Compare |
| v4 | 2021-02-26 | French | Compare |
| v3 | 2021-02-26 | English | Compare |
| v2 | 2021-02-10 | French | Compare |
| v1 | 2021-02-10 | English | Compare |
Showing 1 to 5 of 5